European Investment Bank

Orano is a France-based energy company focused on nuclear power, offering end-to-end capabilities across the nuclear fuel cycle, reactor design and construction, and operating services. It handles transportation, storage, and management of nuclear materials, packaging and transport services, dismantling of nuclear installations, specialized maintenance, and both nuclear and non-nuclear engineering. The company also pursues renewable energy initiatives through partnerships to develop high-technology solutions for low-carbon power generation, combining nuclear and renewable strengths to support safer, lower-emission energy.

Founded in 2015, Infrastrutture Wireless Italiane operates as a leading wireless tower company in Italy. It constructs and manages approximately 24,500 sites, hosting transmission apparatuses for major network operators. The company offers integrated hosting services, including site access management, maintenance, and fiber optic connections. Additionally, it creates indoor and outdoor coverage solutions using micro cells and distributed antenna systems for various public spaces.

Universal Diagnostics, S.L. is a biomedicine company based in Seville, Spain, with an additional office in San Francisco, California. Founded in 2012, the company specializes in developing blood-based diagnostic tests aimed at the early detection of various cancers, including colorectal, lung, breast, liver, pancreatic, and gastric cancers. Its innovative platform utilizes proprietary methylation marker panels, allowing for the analysis of a simple blood sample to identify individuals at risk and facilitate timely medical intervention. The company's flagship assay focuses on colorectal cancer screening, which is critical given the late-stage detection challenges that significantly reduce survival rates. Universal Diagnostics collaborates with international research institutions, hospitals, and biobanks to advance its research and development efforts, striving to transform cancer detection into a more accessible and effective process.

Nomagic, Inc. is a technology company based in Warsaw, Poland, specializing in robotic manipulation solutions for order fulfillment in e-commerce. The company develops smart pick-and-place robotic systems that enhance efficiency, flexibility, and reliability in warehouses. By automating tedious tasks, Nomagic's solutions help reduce fulfillment costs and address labor shortages, allowing operations to scale effectively and operate around the clock. Powered by artificial intelligence, their robotic systems continuously learn and adapt to changing conditions, enabling warehouse operators to improve agility and ensure reliable delivery of goods. Nomagic's technology has been implemented in notable locations, including packing lines at Cdiscount, a leading French eCommerce platform.

Median Technologies develops medical imaging software and services for oncology clinical trials and cancer care. It offers iBiopsy, an AI-powered imaging biomarker phenotyping platform that supports translational research and biomarker identification, and iSee, an image analysis and management solution for clinical trials. The company standardizes and automates the interpretation of medical images to optimize cancer diagnosis and the assessment of treatment response, and provides imaging contract research services such as study startup, image and clinical data management, scientific consulting, independent reviews, image data processing, site support, and study close-out. Median Technologies serves drug development and patient care markets with international reach and has partnerships with industry players to expand imaging capabilities. It was founded in 2002 and is headquartered in Valbonne, France.

EDP Renewables is a global renewable energy company focused on creating value, innovation, and sustainability. Operating in markets worldwide, they are expanding their presence to new regions to lead in each market and provide value to stakeholders and shareholders. With a history of developing wind farms since 1996, EDPR manages assets in the European Union through EDPR Europe and in the United States and Canada through EDPR North America. As a majority shareholder, Energias de Portugal, S.A. (EDP) contributes to EDPR's operational excellence. EDP Group, Portugal's largest industrial group, is a key player in the Iberian Peninsula's energy sector, with interests in electricity and gas generation, distribution, and supply in Portugal, Spain, and Brazil. By focusing on high-quality assets and attractive markets with growth prospects and stable regulatory structures, EDPR aims to generate profits and maintain its position as a leader in the renewable energy industry.

Energias de Portugal (EDP) is a prominent global energy company based in Lisbon, Portugal, founded in 1976. It operates primarily in the electricity and gas sectors, offering services in generation, distribution, and trading. EDP is one of the largest energy operators in the Iberian Peninsula and ranks as the third-largest producer of wind energy in the region. The company emphasizes value creation, innovation, and sustainability, reflecting its commitment to customers, society, and the environment. EDP's diverse workforce spans multiple continents, fostering a culture that respects the various markets in which it operates. Additionally, EDP is recognized for its performance in transparency and sustainability, as evidenced by its inclusion in the Dow Jones Sustainability Indexes.

ERG is a prominent wind power operator based in Italy, recognized as the first of its kind in the country and ranking among the top ten in Europe. With a history spanning 80 years, the company specializes in the production of electricity derived from clean, renewable, and sustainable sources, primarily focusing on wind and hydroelectric power. ERG operates its wind power production through its subsidiary, ENG Renew, which is dedicated to the development, construction, and management of wind energy assets. Additionally, ERG Power Generation oversees the company’s hydroelectric and natural gas operations, which include various plants, dams, reservoirs, and a pumping station. Through its diverse portfolio of sustainable energy sources, ERG contributes significantly to the European energy market.

Cellectis is a clinical-stage biotechnology company specializing in immuno-oncology. It develops allogeneic T-cell therapies using gene-editing technologies, focusing on chimeric antigen receptor (CAR) T-cells targeting various cancers.

Enpal GmbH is a Berlin-based company founded in 2017 that specializes in providing comprehensive renewable energy solutions, primarily through the installation and operation of solar panels for residential electricity generation. The company offers a range of products, including solar panels, batteries, wallboxes, heat pumps, and energy management systems, catering to customers in Germany and Italy. Enpal initially adopted a sales-based model but successfully transitioned to a lease model that requires no upfront payment and includes installation, insurance, and maintenance services. This approach has resulted in significant growth, with over 60,000 solar PV systems installed and revenues exceeding 400 million euros as of 2022. Enpal employs more than 1,000 team members, including over 200 local installer teams, and has opened several satellite offices to enhance customer service across its markets. The company has received numerous awards for its contributions to sustainability and customer service, positioning itself as a leader in the solar PV installation sector in Germany.

Founded in Lyon, France in 2009 and part of the LyonBiopôle cluster, Fab’entech is a biopharmaceutical company developing and commercializing innovative passive immunotherapeutic solutions. These are based on specific polyclonal immunoglobulins [F(ab’)₂] for treating emerging infectious diseases and certain drug intoxications.

Nexi specializes in payment services across Europe, offering merchant acquiring, card issuing, and digital banking solutions. It partners with banks and serves merchants directly, covering the entire payment chain excluding card schemes.

Cyprus University of Technology (CUT) provides education and research in subjects that create significant economic, technological, and scientific developments. The University established in 2004, is a public institution located in Limassol that offers a comprehensive educational experience. CUT is known for providing quality education and conducting research in areas that contribute to economic, technical, and scientific advancements. With a focus on applied research, the university addresses significant challenges in science, technology, and knowledge, aiming to benefit both the state and society.

Stark Future, founded in 2019 by Anton Wass and Paul Soucy, is a Spanish company with Swedish origins, dedicated to revolutionizing the motorcycle industry through sustainable technologies. Located near Barcelona, the company aims to reduce emissions and pollution by producing high-performance electric motorcycles using eco-friendly materials. The Stark VARG, launched in December 2021, exemplifies this mission; it features an 80-horsepower, near-silent engine and advanced technologies such as a smartphone dashboard and a bike setup app. The development of the VARG involved eight patented innovations and garnered significant attention, achieving €9 million in advance sales within the first 24 hours and generating €50 million in its first month. Within two months of its launch, Stark Future sold over 5,000 motorcycles, positioning itself as a leader in the sustainable mobility sector. The company is also noted for its team, which includes former motocross world champion Sebastien Tortelli as test manager, further emphasizing its commitment to performance and innovation.

Elektrodistribucija Srbije doo Belgrade is a Serbian Public Electric Utility Company.

Iren operates as a multi-utility company in Italy, focusing on electricity production and distribution, natural gas distribution, integrated water cycle management, waste management, and provision of related services. It serves approximately 721,000 electrical customers, 743,000 gas customers, and 2.8 million residents through its extensive networks.

Inventiva Pharma is a clinical-stage biopharmaceutical company based in France, dedicated to developing oral small molecule therapies aimed at addressing significant unmet medical needs in fibrosis, lysosomal storage disorders, and oncology. The company has established a robust pipeline supported by a proprietary discovery engine and a wholly-owned research and development facility. It possesses an extensive library of molecules and a team with considerable expertise in developing compounds that target nuclear receptors, transcription factors, and epigenetic modulation. Inventiva is advancing clinical candidates, including lanifibranor, which is being developed for non-alcoholic steatohepatitis (NASH), a condition currently lacking approved treatments. Additionally, the company is engaged in a variety of pre-clinical therapy programs, further strengthening its portfolio in the fields of oncology, fibrosis, and rare diseases.

Metlen Energy & Metals is a global industrial and energy company with a growing position in the metals and energy sectors, focused on sustainable development and the circular economy. It operates across the Energy Sector, the Metals Sector, the Infrastructure and Concessions Sector, and other activities. The company develops, constructs, and operates thermal units and renewable energy projects, designs and builds electricity infrastructure, and provides retail electricity and natural gas supply, gas trading, and related energy products and services.

Inbrain Neuroelectronics is a medical device company that designs and commercializes graphene-based neural interfaces and intelligent neuromodulation systems to treat brain disorders. The core platform is an implantable system that decodes brain activity with high resolution and provides focal, adaptive stimulation, enabling real-time precision neurology and autonomous therapy adjustments. This approach aims to maximize therapeutic outcomes while minimizing side effects for conditions such as Parkinson’s disease, epilepsy, and stroke rehabilitation. The company pursues strategic collaborations to extend its solutions to peripheral nerve and systemic disease applications, expanding the potential of neurotechnology and bioelectronics.

Energy Dome develops a low-cost, efficient system for long-duration electricity storage using liquid CO2. Its focus is on enabling dispatchable renewable energy production to facilitate the decarbonization of the energy industry and promote sustainability.

Hellenic Electricity Distribution Network Operator is a prominent electricity provider based in Athens, Greece, serving approximately 7.5 million consumers. The company manages an extensive network comprising 240,000 kilometers of medium and low voltage power lines. Its core functions include the maintenance and development of the power distribution network, ensuring transparent access for all consumers and network users. By focusing on reliability and economic efficiency, the operator aims to enhance the quality of life for citizens through dependable electricity supply.

Amplifon is a leading international provider of hearing care solutions and services, dedicated to helping individuals rediscover the joys of sound. The company offers a wide range of customizable hearing products that are tailored to meet the unique needs of consumers. Amplifon operates through a comprehensive distribution network that includes corporate shops, franchises, and shop-in-shops, allowing it to reach various markets effectively. It has a significant presence in the EMEA region, which accounts for most of its revenue, while also having a footprint in the Americas and Asia-Pacific. Amplifon markets its offerings under several brands, including Amplifon, Beter Horen, Maxtone, and Miracle-Ear, with a notable concentration of retail locations in Italy. Through its commitment to innovative technology and personalized service, Amplifon strives to deliver the highest quality hearing care experience to its customers.

Repsol is a Spanish integrated energy company with global reach, providing oil and gas, downstream refining, and a growing portfolio of sustainable energy products and services. It pursues innovation to develop a new energy model and operates across regions including Brazil, Russia, and the United States. In 2024, it reported production of about 571,000 barrels of oil equivalent per day, proven reserves of roughly 1.8 billion barrels of oil equivalent, a refining capacity of about 1.0 million barrels per day, and 3.7 gigawatts of installed renewable power generation capacity.

Endesa is a leading electric utility company operating primarily in Spain and Portugal since its founding in 1944. It generates electricity from diverse sources including hydroelectric, nuclear, natural gas, oil, solar, and wind, with an installed capacity of over 21 gigawatts. Endesa serves approximately 11.2 million customers and employs around 10,000 people directly.

Iberdrola is a global utility company focused on the production, distribution, and retail of electricity and gas. It generates power from nuclear, hydro, and other sources, with a substantial share from renewables, and is a major owner of wind energy. The company operates electricity networks and distribution assets across multiple countries and serves customers in a broad geographic footprint, including Spain, the United Kingdom, Brazil, and the United States, with activity in nearly 40 countries. Iberdrola emphasizes the energy transition through a sustainable business model built on renewable energy, smart grids, large-scale energy storage, and digital transformation to offer advanced products and services.

Telecom Italia provides technological infrastructures and platforms for voice and data, delivering advanced telecommunications services and ICT and media solutions. It builds nationwide fiber fixed-line network infrastructure and offers international connectivity through Sparkle, alongside mobile and fixed-line telephony products and support for small and medium enterprises undergoing digitalization with tailored solutions. As Italy's incumbent operator, the group maintains a substantial presence in mobile and broadband markets; after selling its fixed-network assets to KKR, it positions itself primarily as a services provider. It also operates TIM Brasil, where wireless market share is smaller than that of its peers.

Illimity Bank, founded in 2018 and headquartered in Milan, Italy, is a commercial bank that delivers digital direct banking services to both retail and business clients. The bank specializes in providing corporate credit, managing non-performing loan (NPL) portfolios, and offering financing solutions specifically tailored for small and medium-sized enterprises (SMEs). Additionally, Illimity Bank engages in investment banking activities, including the establishment and management of investment funds and facilitating initial public offerings. With a focus on addressing the challenges posed by distressed credit and the increasing prevalence of bad loans, Illimity Bank aims to support its clients through innovative financial solutions.

SiPearl is a French semiconductor company specializing in designing high-performance, low-power microprocessors for exascale supercomputers. Its flagship product, Rhea, based on Arm Neoverse V1 architecture and manufactured using TSMC's N6 or better processes, aims to advance computing infrastructure for critical applications such as HPC, AI, and data centers.

Reden Solar develops, finances, builds, and operates solar photovoltaic power plants across Europe and Latin America. The company has an installed portfolio of 762 MW and a development pipeline of about 15 GW. Its core markets are France and Spain, with recent expansion into Greece and Italy. Reden Solar offers a range of photovoltaic installations, including agricultural greenhouses, ground-mounted plants, photovoltaic shelters, and rooftops, enabling clients to generate clean energy.

Orange is a global telecommunications company, founded in 1991 and headquartered in Paris, France. It operates in 30 countries across Europe and Africa, providing mobile and internet services to consumers, and corporate telecommunication services worldwide. Through its business arm, Orange Business Services, it caters to large corporates, local authorities, and SMEs, offering a comprehensive range of voice and data, IT, and integrated services. Additionally, Orange supports digital innovation through its international network of startup accelerators, Orange Fabs, which provides resources and expertise to startups in the digital space.

Iberdrola is a global utility company focused on the production, distribution, and retail of electricity and gas. It generates power from nuclear, hydro, and other sources, with a substantial share from renewables, and is a major owner of wind energy. The company operates electricity networks and distribution assets across multiple countries and serves customers in a broad geographic footprint, including Spain, the United Kingdom, Brazil, and the United States, with activity in nearly 40 countries. Iberdrola emphasizes the energy transition through a sustainable business model built on renewable energy, smart grids, large-scale energy storage, and digital transformation to offer advanced products and services.

AB Science, established in 2001 by a team of researchers, clinicians, and entrepreneurs, is a France-based pharmaceutical company focused on developing innovative treatments for significant unmet medical needs. The company specializes in the research, discovery, development, and marketing of protein kinase inhibitors, particularly tyrosine kinase inhibitors. These targeted therapies aim to treat various diseases, including cancer, chronic inflammatory diseases, neurological degenerative disorders, and central nervous system diseases, with applications in both human and veterinary medicine.

Independent Power Transmission Operator owns, operates, and maintains Greece's electricity transmission system to ensure a safe, efficient, and reliable power supply. Founded in 2000 and based in Athens, it oversees the operation and development of the transmission network and the Greek electricity market in line with transparency, equality, and open competition. It is a subsidiary of ADMIE Holdings.

Cellectis is a clinical-stage biotechnology company specializing in immuno-oncology. It develops allogeneic T-cell therapies using gene-editing technologies, focusing on chimeric antigen receptor (CAR) T-cells targeting various cancers.

AB Science, established in 2001 by a team of researchers, clinicians, and entrepreneurs, is a France-based pharmaceutical company focused on developing innovative treatments for significant unmet medical needs. The company specializes in the research, discovery, development, and marketing of protein kinase inhibitors, particularly tyrosine kinase inhibitors. These targeted therapies aim to treat various diseases, including cancer, chronic inflammatory diseases, neurological degenerative disorders, and central nervous system diseases, with applications in both human and veterinary medicine.

Advicenne is a late-stage biopharmaceutical company established in 2007 and headquartered in Nîmes, France. It focuses on developing and commercializing innovative treatments for unmet medical needs in nephrology, particularly for orphan renal diseases and niche neurology indications. The company's lead drug candidate, ADV7103, is currently undergoing late-stage clinical trials for two specific conditions: distal renal tubular acidosis (dRTA) and cystinuria. Advicenne aims to create pediatric-friendly therapeutics that enhance the quality of life for patients from early childhood through adulthood.

OVH APAC is a leading cloud provider known for its innovative and cost-effective solutions tailored for a diverse clientele, ranging from startups to large enterprises. Founded in 1999 by Octave Klaba and based in France, OVH offers a comprehensive portfolio of services, including web hosting, dedicated servers, cloud solutions, domain registration, and VOIP telephony. The company distinguishes itself through its proprietary global fiber-optic network and green data centers, which enable optimal performance and reliability. With a commitment to research and development and complete control over its supply chain, OVH delivers high-quality products and exceptional customer service. Additionally, OVH has established a strong partnership with VMware, integrating advanced software solutions to enhance network performance and streamline service delivery for its customers. As a result, OVH is recognized as one of the top internet hosting companies globally, serving millions of customers with cutting-edge technology and expertise.

MedinCell S.A. is a pharmaceutical company focused on developing innovative therapeutic solutions through its proprietary BEPO technology, which facilitates long-acting injectable products utilizing biodegradable polymers and a biocompatible solvent. Based in Jacou, France, the company is engaged in ongoing research and development to optimize the efficiency and accessibility of medical treatments across various therapeutic areas. MedinCell's product pipeline includes several candidates, such as mdc-IRM, a subcutaneous injection for schizophrenia currently in Phase III trials, and mdc-CWM, an intra-articular injection aimed at treating pain and inflammation. Additionally, the company is exploring formulations like mdc-WWM for contraception and mdc-ANG for central nervous system disorders, alongside other candidates targeting pain management and organ transplant applications. Through its advancements in controlled, long-acting injectables, MedinCell aims to enhance treatment outcomes for patients.

The International Fund for Agricultural Development (IFAD) is a United Nations agency established in 1977 and headquartered in Rome, Italy. It focuses on agricultural development in developing countries by providing grants and low-interest loans to rural projects. IFAD aims to empower rural populations to enhance food security, improve nutrition, and increase their incomes. In addition to financing sovereign governments, IFAD has adopted a private sector investment strategy to support small and medium-sized enterprises, cooperatives, and smallholder farmers. This approach allows IFAD to fund a diverse range of initiatives that boost productivity, promote climate-smart practices, and foster resilience among rural communities. By attracting private sector funding, IFAD expands its capacity to contribute to sustainable agricultural development and poverty reduction in rural areas.

GenSight Biologics is a clinical-stage biotechnology company focused on developing therapies for mitochondrial and neurodegenerative diseases of the eye. It uses gene therapy-based platforms, Mitochondrial Targeting Sequence and Optogenetics, to preserve or restore vision in patients with severe degenerative retinal diseases.

Autonom Group is a family-owned mobility network that specializes in transportation and car rental services across Romania, Hungary, and Serbia. The company offers a comprehensive range of services, including car rentals, purchase-use vehicles, operating leases, equipment leases, road assistance, transfer services, and fleet management. Autonom Group is committed to long-term growth driven by client satisfaction and the development of its employees. The company prioritizes profitability and financial stability as natural outcomes of its focus on customer service and employee evolution.

Prophesee develops neuromorphic vision systems that mimic the human eye's functionality. Its patented sensors and AI algorithms enable unprecedented speed (>10,000 fps), dynamic range (>120dB), data volume reduction (10x to 1000x), and power efficiency (<10 mW). Prophesee serves clients in autonomous driving, mobile devices, IoT, and industry sectors. Founded in Paris in 2014 by Ryad Benosman, Bernard Gilly, Christoph Posch, and Luca Verre, the company is backed by leading international investors.

MithraSol specialises in the identification, development, construction and operation of Spanish solar photovoltaic assets and currently has 50MW of assets in development across twelve projects spanning central and southern Spain.

Opdenergy is a renewable energy company with over 15 years of expertise, specializing in solar photovoltaic and onshore wind energy. The company has a diverse portfolio of projects across various renewable technologies. Opdenergy operates in Chile, Italy, Mexico, the USA, and Spain, with the majority of its revenue generated from Spain.

Iberdrola is a global utility company focused on the production, distribution, and retail of electricity and gas. It generates power from nuclear, hydro, and other sources, with a substantial share from renewables, and is a major owner of wind energy. The company operates electricity networks and distribution assets across multiple countries and serves customers in a broad geographic footprint, including Spain, the United Kingdom, Brazil, and the United States, with activity in nearly 40 countries. Iberdrola emphasizes the energy transition through a sustainable business model built on renewable energy, smart grids, large-scale energy storage, and digital transformation to offer advanced products and services.

Nomagic, Inc. is a technology company based in Warsaw, Poland, specializing in robotic manipulation solutions for order fulfillment in e-commerce. The company develops smart pick-and-place robotic systems that enhance efficiency, flexibility, and reliability in warehouses. By automating tedious tasks, Nomagic's solutions help reduce fulfillment costs and address labor shortages, allowing operations to scale effectively and operate around the clock. Powered by artificial intelligence, their robotic systems continuously learn and adapt to changing conditions, enabling warehouse operators to improve agility and ensure reliable delivery of goods. Nomagic's technology has been implemented in notable locations, including packing lines at Cdiscount, a leading French eCommerce platform.

Inventiva Pharma is a clinical-stage biopharmaceutical company based in France, dedicated to developing oral small molecule therapies aimed at addressing significant unmet medical needs in fibrosis, lysosomal storage disorders, and oncology. The company has established a robust pipeline supported by a proprietary discovery engine and a wholly-owned research and development facility. It possesses an extensive library of molecules and a team with considerable expertise in developing compounds that target nuclear receptors, transcription factors, and epigenetic modulation. Inventiva is advancing clinical candidates, including lanifibranor, which is being developed for non-alcoholic steatohepatitis (NASH), a condition currently lacking approved treatments. Additionally, the company is engaged in a variety of pre-clinical therapy programs, further strengthening its portfolio in the fields of oncology, fibrosis, and rare diseases.

Cabify, established in 2011 and based in Madrid, Spain, is a ride-sharing company that facilitates transportation for both individuals and businesses. It offers a user-friendly web and mobile app for booking rides, connecting users with suitable transport options. Cabify prioritizes customer satisfaction, ensuring fair pricing, comfortable journeys, and accessibility for all. Its services include clean, modern vehicles driven by trained professionals, providing safe and reliable rides with added amenities like music and magazines. The company aims to enhance urban mobility and improve cities and communities by making transportation better.

Priothera is a clinical-stage biotechnology company developing orally administered sphingosine-1-phosphate (S1P) receptor modulators for hematological malignancies. The company focuses on reducing the egress of T cell subsets from lymphatic tissue to enhance the curative potential of allogeneic hematopoietic stem cell transplantation, enabling dual inhibition of graft-versus-host disease while strengthening graft-versus-leukemia effects. Its lead program, mocravimod, aims to improve outcomes for patients undergoing HSCT. Priothera was incorporated in 2020 and is based in Dublin, Ireland, with an additional location in Saint Louis, France.

Stilla Technologies is a Paris-based biotechnology company that accelerates genetic test development by delivering the Naica System, a digital PCR (dPCR) platform. Built on microfluidic innovations, the Naica System aims to broaden dPCR from a specialized tool to a widely accessible technology across life sciences, including research, therapeutics, and omics. The platform supports multiple chemistries and multiplexing to enable high-resolution genetic analysis and actionable insights across applications such as cancer and liquid biopsy, cell and gene therapies, infectious disease detection, and food and environmental testing. Founded in 2013 and headquartered in Villejuif, France, the company serves customers globally and focuses on simplifying image analysis and data exploration to help researchers derive clear results from complex genomic data.

Founded in 2015, Infrastrutture Wireless Italiane operates as a leading wireless tower company in Italy. It constructs and manages approximately 24,500 sites, hosting transmission apparatuses for major network operators. The company offers integrated hosting services, including site access management, maintenance, and fiber optic connections. Additionally, it creates indoor and outdoor coverage solutions using micro cells and distributed antenna systems for various public spaces.

OSE Immunotherapeutics SA is a clinical-stage biotechnology company based in Nantes, France, specializing in the development of innovative immunotherapies aimed at immune activation and regulation, particularly in the areas of immuno-oncology and autoimmune diseases. The company's product portfolio includes Tedopi, which is in Phase III clinical trials for lung cancer and Phase II for pancreatic cancer; BI 765063, currently in Phase I trials for solid tumors; and OSE-703, a humanized monoclonal antibody in preclinical development for various cancers. Additionally, OSE Immunotherapeutics is advancing FR104, which is in Phase I trials for rheumatoid arthritis, and OSE-127, a humanized monoclonal antibody in Phase I trials for inflammatory autoimmune diseases. The company collaborates with notable partners such as GERCOR, Memorial Sloan Kettering Cancer Center, Boehringer Ingelheim, Servier, and HalioDx. OSE Immunotherapeutics was previously known as OSE Pharma SA before its name change in May 2016.

Red Points is a technology company based in Barcelona, Spain, that specializes in online brand protection. Founded in 2011, the company offers a software-as-a-service platform designed to combat online counterfeiting, digital piracy, and distribution fraud. Utilizing advanced machine learning and computer vision techniques, Red Points' software effectively detects and removes counterfeit goods and pirated content from the internet. The platform operates across more than one hundred online marketplaces and social networks, addressing hundreds of thousands of incidents each month. With a client base that includes over five hundred brands worldwide, such as Bang & Olufsen, MVMT, and DOPE, Red Points provides essential solutions for brands and content owners seeking to safeguard their intellectual property rights in the digital landscape.

Bouygues Telecom is a prominent telecommunications operator in France, offering a wide range of services that include mobile, fixed-line, television, internet, and cloud computing. The company serves approximately 11.1 million mobile customers and 2.1 million fixed broadband customers, including over 1.5 million professional and corporate clients. Renowned for its innovative approach, Bouygues Telecom has introduced several pioneering products, such as the first unlimited call plans, fixed-mobile convergence offers for corporate customers, and the quadruple play solution known as ideo. The company also launched B&YOU, a web-only offer that revolutionized mobile telephony. With a mobile network that covers 99% of the population and a rapidly expanding 4G network, Bouygues Telecom is committed to enhancing customer experience through its dedicated team of over 9,000 employees and a robust customer service framework that includes 2,000 advisers and 2,500 sales staff. The company's focus on innovation and customer satisfaction positions it as a key player in the French telecommunications market.

Worldsensing specializes in Internet of Things (IoT) solutions, focusing on mobility and industrial applications. Its portfolio includes Bitcarrier for real-time traffic flow management and Fastprk for smart parking systems. Additionally, Worldsensing offers the LS-G6 platform to monitor critical assets in remote locations such as bridges, tunnels, and mines. With offices in Barcelona and London, the company employs over 40 professionals.

Iliad Italia is an Italian telecommunications company offering mobile telecommunication services. It provides prepaid and postpaid voice calling, SMS packages, and internet services with integrated 2G, 3G, and 4G networks.

Advicenne is a late-stage biopharmaceutical company established in 2007 and headquartered in Nîmes, France. It focuses on developing and commercializing innovative treatments for unmet medical needs in nephrology, particularly for orphan renal diseases and niche neurology indications. The company's lead drug candidate, ADV7103, is currently undergoing late-stage clinical trials for two specific conditions: distal renal tubular acidosis (dRTA) and cystinuria. Advicenne aims to create pediatric-friendly therapeutics that enhance the quality of life for patients from early childhood through adulthood.

Iberdrola is a global utility company focused on the production, distribution, and retail of electricity and gas. It generates power from nuclear, hydro, and other sources, with a substantial share from renewables, and is a major owner of wind energy. The company operates electricity networks and distribution assets across multiple countries and serves customers in a broad geographic footprint, including Spain, the United Kingdom, Brazil, and the United States, with activity in nearly 40 countries. Iberdrola emphasizes the energy transition through a sustainable business model built on renewable energy, smart grids, large-scale energy storage, and digital transformation to offer advanced products and services.

Resalta is an energy efficiency company based in Ljubljana-Črnuče, Slovenia, founded in 2011. The company specializes in providing innovative solutions to enhance energy consumption management and reduce environmental impact for clients across various sectors, including food, manufacturing, automotive, and finance. Resalta develops and implements energy efficiency projects tailored to the specific needs of its clients, conducting thorough analyses to optimize their energy use. In addition to its energy efficiency services, Resalta also focuses on developing renewable energy projects, contributing to the overall increase in renewable energy adoption in the countries where it operates. The company's mission is to help clients improve their business competitiveness while promoting sustainable practices.

Median Technologies develops medical imaging software and services for oncology clinical trials and cancer care. It offers iBiopsy, an AI-powered imaging biomarker phenotyping platform that supports translational research and biomarker identification, and iSee, an image analysis and management solution for clinical trials. The company standardizes and automates the interpretation of medical images to optimize cancer diagnosis and the assessment of treatment response, and provides imaging contract research services such as study startup, image and clinical data management, scientific consulting, independent reviews, image data processing, site support, and study close-out. Median Technologies serves drug development and patient care markets with international reach and has partnerships with industry players to expand imaging capabilities. It was founded in 2002 and is headquartered in Valbonne, France.

MolMed S.p.A. is an Italian medical biotechnology company dedicated to the research, development, and clinical validation of innovative therapies for cancer treatment. The company’s pipeline features several promising antitumor therapeutics in various stages of development. Zalmoxis® (TK) is a cell-based therapy designed to facilitate bone marrow transplants from partially compatible donors without the need for post-transplant immune suppression; it is currently in Phase III trials for high-risk acute leukemia and is under evaluation for Conditional Marketing Authorization. NGR-hTNF, another therapeutic agent, targets solid tumors through specific binding to the blood vessels that supply the tumor mass and is part of an extensive clinical program. Additionally, MolMed is advancing CAR-CD44v6, an immuno-gene therapy project aimed at treating multiple hematological malignancies and certain epithelial tumors, which is currently in preclinical development. The company also engages in cell and gene therapy projects in collaboration with external partners, providing resources and expertise throughout the development process, from preclinical studies to Phase III trials.

Orange is a global telecommunications company, founded in 1991 and headquartered in Paris, France. It operates in 30 countries across Europe and Africa, providing mobile and internet services to consumers, and corporate telecommunication services worldwide. Through its business arm, Orange Business Services, it caters to large corporates, local authorities, and SMEs, offering a comprehensive range of voice and data, IT, and integrated services. Additionally, Orange supports digital innovation through its international network of startup accelerators, Orange Fabs, which provides resources and expertise to startups in the digital space.

Prophesee develops neuromorphic vision systems that mimic the human eye's functionality. Its patented sensors and AI algorithms enable unprecedented speed (>10,000 fps), dynamic range (>120dB), data volume reduction (10x to 1000x), and power efficiency (<10 mW). Prophesee serves clients in autonomous driving, mobile devices, IoT, and industry sectors. Founded in Paris in 2014 by Ryad Benosman, Bernard Gilly, Christoph Posch, and Luca Verre, the company is backed by leading international investors.

FlixBus, operated by FlixMobility, is a notable provider of intercity travel, focusing on affordable, convenient, and environmentally-friendly transportation solutions. Since its inception in 2013, the company has established Europe's largest long-distance bus network and introduced green long-distance trains in 2018, alongside a pilot for all-electric buses in Germany and France. The platform offers travelers a sustainable alternative to private transportation, featuring amenities such as free WiFi, flexible online booking, and innovative ticketing systems. FlixBus also expanded its services to the United States in 2018, bringing its unique travel model to a broader audience. By collaborating with regional bus partners and private train companies, FlixMobility combines technological innovation with traditional transportation expertise, positioning itself as a leader in the evolving mobility landscape. As a result, FlixBus has transformed the travel experience for over 100 million people across Europe and the United States while contributing to job creation in the mobility sector.

Mobidiag is a Finnish-French biotechnology company specializing in the development and marketing of molecular diagnostic solutions aimed at detecting gastrointestinal infections, antimicrobial resistance, healthcare-associated infections, respiratory infections, and sepsis. The company utilizes established technologies such as real-time polymerase chain reaction (qPCR) and microarray to create a wide array of diagnostic tests and automated platforms. These solutions are designed to be fast, reliable, and cost-effective, catering to laboratories of various sizes. Mobidiag's offerings enable the detection of a majority of clinically relevant pathogens, including bacteria, parasites, and viruses, as well as important markers for antibiotic resistance, thereby enhancing diagnostic capabilities in hospitals, laboratories, and clinics.

Carmat is a French medtech company that specializes in the development and manufacturing of bioprosthetic artificial hearts. Founded in 2008 and headquartered in Vélizy-Villacoublay, the company creates biocompatible, auto-regulated total artificial hearts designed to closely mimic the human heart's structure, including both right and left ventricles. These devices are intended for patients suffering from chronic terminal heart failure classified as class IV by the New York Heart Association, as well as those experiencing acute terminal heart failure due to massive myocardial infarction. Carmat aims to provide a reliable and innovative therapeutic solution for heart failure patients who are ineligible for transplants and have exhausted other treatment options. In addition to the artificial hearts, the company develops the necessary power supply systems and remote diagnostic systems for these devices.

MotorK is a SaaS provider specializing in digital sales and marketing solutions for the automotive retail industry across EMEA. With over 400 employees and offices in eight countries, MotorK empowers car manufacturers and dealers to enhance customer experience through integrated digital products and services.

Mobidiag is a Finnish-French biotechnology company specializing in the development and marketing of molecular diagnostic solutions aimed at detecting gastrointestinal infections, antimicrobial resistance, healthcare-associated infections, respiratory infections, and sepsis. The company utilizes established technologies such as real-time polymerase chain reaction (qPCR) and microarray to create a wide array of diagnostic tests and automated platforms. These solutions are designed to be fast, reliable, and cost-effective, catering to laboratories of various sizes. Mobidiag's offerings enable the detection of a majority of clinically relevant pathogens, including bacteria, parasites, and viruses, as well as important markers for antibiotic resistance, thereby enhancing diagnostic capabilities in hospitals, laboratories, and clinics.

Navya SA is a prominent French company specializing in autonomous vehicle technology and smart shared mobility solutions. Founded in 2014 and headquartered in Villeurbanne, France, Navya develops, manufactures, and services a range of driverless electric vehicles, including autonomous shuttles and cabs. The company primarily caters to municipalities, industrial sites, universities, theme parks, and airports, and its products are available in the United States, EMEA, and Asia-Pacific regions. Navya has been a pioneer in the autonomous mobility sector, launching its first shuttle, the AUTONOM®SHUTTLE, in 2015, with over 100 units produced and sold in multiple countries. The AUTONOM®CAB, introduced in 2017, is set to undergo road tests soon. With a workforce of more than 200 employees in France and the United States, Navya combines advanced robotic and digital technologies to deliver innovative mobility solutions.

MedinCell S.A. is a pharmaceutical company focused on developing innovative therapeutic solutions through its proprietary BEPO technology, which facilitates long-acting injectable products utilizing biodegradable polymers and a biocompatible solvent. Based in Jacou, France, the company is engaged in ongoing research and development to optimize the efficiency and accessibility of medical treatments across various therapeutic areas. MedinCell's product pipeline includes several candidates, such as mdc-IRM, a subcutaneous injection for schizophrenia currently in Phase III trials, and mdc-CWM, an intra-articular injection aimed at treating pain and inflammation. Additionally, the company is exploring formulations like mdc-WWM for contraception and mdc-ANG for central nervous system disorders, alongside other candidates targeting pain management and organ transplant applications. Through its advancements in controlled, long-acting injectables, MedinCell aims to enhance treatment outcomes for patients.

October is a pan-European lending platform that aims to empower businesses by simplifying access to funding. Founded in France in 2014 under the name Lendix, the company emerged following regulatory changes that disrupted traditional banking practices. With offices in France, Spain, Italy, and the Netherlands, October operates an online marketplace that connects private investors with enterprises of various sizes. This platform allows investors to finance businesses directly, offering fully disclosed terms and facilitating a streamlined investment process. Institutional lenders complement individual contributions, ensuring borrowers benefit from high success rates and quick processing times. October's mission is to democratize finance, providing a secure and efficient way for individuals to invest in the real economy.

Enterome develops innovative cancer treatments focusing on generating powerful, long-lasting immune responses using its proprietary OncoMimic technology. The company aims to overcome immune tolerance against cancer cells, with applications across various solid tumors. Its most advanced programs are in Phase 2 clinical trials for hard-to-treat tumors such as glioblastoma, adrenal malignancies, and colorectal cancer.

Forsee Power SAS, founded in 2007 and based in Ivry-sur-Seine, France, specializes in the design and manufacture of smart lithium-ion battery systems. The company serves various sectors, including electric transportation, portable and mobile equipment, and energy storage. Its product offerings include modular battery systems for electric and hybrid vehicles, trams, electric trains, buses, trucks, and marine applications such as ships and ferries. Additionally, Forsee Power provides power systems for mobile and connected devices across numerous fields, including medical equipment, electric scooters, and robotics. The company's focus on innovation and customer satisfaction aims to facilitate a sustainable energy transition and enhance the performance of smart mobility and life devices globally.

SunPartner Technologies, founded in 2008 and based in Rousset, France, specializes in the development and commercialization of advanced photovoltaic technologies. The company focuses on integrating solar solutions into various applications, including mobile devices and infrastructure. Its notable products include Wysips Crystal, an ultra-thin and transparent photovoltaic material designed for smartphones and smartwatches, and Wysips Graphics, which incorporates solar cells into connected devices. Additionally, SunPartner offers Wysips Reflect for reflective screens and Wysips Cameleon for signage and billboards. The company also explores innovations in communication technologies, such as Light-Fidelity, which utilizes visible light for data transmission, applicable in smart cities and location-based services. Through its diverse portfolio, SunPartner aims to enhance energy autonomy and promote sustainable energy solutions in multiple sectors.

iZettle AB is a financial technology company based in Stockholm, Sweden, that specializes in mobile payment services and applications designed for small businesses and entrepreneurs. Founded in 2010, it revolutionized the industry with the introduction of the first mini chip card reader, enabling businesses to accept card payments through smartphones and tablets. iZettle offers a range of products, including the iZettle Card Reader Lite and an application compatible with iOS and Android devices, which facilitate payment processing, business management, sales analytics, and customer engagement. The company serves a diverse clientele across several countries, including Sweden, Norway, Denmark, Finland, the United Kingdom, Germany, Spain, Mexico, the Netherlands, and Brazil. As of 2018, iZettle operates as a subsidiary of PayPal Holdings, Inc.

Electro Power Systems operates in the sustainable energy sector, focusing on hybrid-storage solutions and microgrids that convert intermittent renewable energy into a reliable power source. Headquartered in Paris, with research, development, and manufacturing facilities in Italy, the company has developed innovative hybrid energy storage technologies, supported by 125 patents and over a decade of research and development. These solutions are designed to stabilize electrical grids with high levels of renewable energy integration in developed countries and provide cost-effective off-grid power in emerging economies without relying on subsidies. Electro Power Systems has successfully implemented and is commissioning 36 large-scale projects, including off-grid hybrid systems and grid support systems, totaling over 47 MWh of capacity across 21 countries, serving more than 165,000 customers daily.

Upstream S.A. is a mobile marketing technology company that operates the MINT platform, designed to enhance mobile commerce in high-growth markets. Founded in 2001 and headquartered in Athens, Greece, Upstream provides a comprehensive suite of mobile solutions, including marketing promotions, mobile content, loyalty programs, and advanced credit services. The company integrates with over 50 mobile operators across 43 markets, enabling 1.2 billion consumers to access and pay for digital subscription services seamlessly via their mobile devices. By tailoring high-value digital services to local market conditions and utilizing direct carrier billing, Upstream has successfully engaged half a billion consumers, converting 65 million into paying customers through subscription micro-payment models. With additional offices in key cities such as London, New York, Rio de Janeiro, and Dubai, Upstream aims to drive mobile commerce growth globally.

Mobidiag is a Finnish-French biotechnology company specializing in the development and marketing of molecular diagnostic solutions aimed at detecting gastrointestinal infections, antimicrobial resistance, healthcare-associated infections, respiratory infections, and sepsis. The company utilizes established technologies such as real-time polymerase chain reaction (qPCR) and microarray to create a wide array of diagnostic tests and automated platforms. These solutions are designed to be fast, reliable, and cost-effective, catering to laboratories of various sizes. Mobidiag's offerings enable the detection of a majority of clinically relevant pathogens, including bacteria, parasites, and viruses, as well as important markers for antibiotic resistance, thereby enhancing diagnostic capabilities in hospitals, laboratories, and clinics.

The company develops and delivers technology for converting ocean waves to electricity. AW-Energy has developed WaveRoller - a fully submerged wave energy converter which utilizes wave surge phenomenon. This commonplace effect is observed in near-shore waters where the circular motion of water particles present in open sea waves changes into elliptical circulation due to more shallow bottom. Before the waves break, typically at the depth of 8-20 metres this elliptical motion is so flat that it is essentially a horizontal back-and-forth movement of water. WaveRoller device is a Panel anchored at its base on the sea bed. The back and forth movement of the wave surge moves the Panel, transferring the kinetic energy to piston pumps. The pumps create a great deal of pressure which is fed into a combination of hydraulic motor/generator, which in turn produces electricity. The nominal capacity of a single commercial-scale Panel ranges between 500 – 1000 kW, depending on the wave resources available on the site. WaveRoller has the ability to generate energy on a wide spectrum of wave states and is also well suited for locations where wave periods are long and the swell is strong. A series of WaveRoller devices can be combined into an array, thus resulting in a wave farm. Since the plant construction is modular with a high degree of independence between individual units, there is no natural upper limit to the number of WaveRoller units that can be used, therefore offering a high level of scalability and reliability. The electricity output from an individual Panel is connected to a hub/substation, thus making it easy to plug-in new units in separate project development stages, as the new capacity is added to the farm. Also, any potential underperformance or service & maintenance breaks of individual units have no impact on the remaining units, thus ensuring uninterrupted power output from the overall farm. The first prototypes were designed and patent applications were filed as early as in 1999, when Rauno Koivusaari, the original inventor co-operated with Fortum Research Centre during the conceptual phase. Since then the technology has evolved following numerous laboratory and wave-tank test trials and ongoing mathematical simulations. Open sea trails started in 2004 and included the Gulf of Finland, marine tests conducted in the European Marine Energy Centre (EMEC), Scotland, and an own testing site in Peniche, Portugal. The subsequent successes and encouraging test results led to continuous increase in the scale of the demonstration plant. The latest demonstration plant/farm consisting of three 100kW WaveRoller units (total nominal capacity of the farm 300kW) is to be deployed in Peniche, Portugal, during the second quarter of 2012. The final assembly is nearing completion in the first quarter of 2012 and will be awaiting suitable weather conditions for the deployment in the following months. The farm will be connected to national grid in Portugal. The company has already secured all the necessary permits and, additionally, holds a licence for 1MW grid connection.

Bordeaux Métropole Énergies (BME) is a semi-public energy group headquartered in Bordeaux, France, and is 76% controlled by Bordeaux Métropole. BME is an important actor in the local energy transformation, servicing the Gironde region and the surrounding Bordeaux metropolitan area.